Archit Organosys Ltd Stock Price Today (NSE: ARCHITORG)
Fundamental Score
Archit Organosys Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Archit Organosys Ltd share price today is ₹36.16, down 4.29% on NSE/BSE as of 30 March 2026. Archit Organosys Ltd (ARCHITORG) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of ₹82.68 (Cr). The 52-week high for ARCHITORG share price is ₹51.45 and the 52-week low is ₹34.00. At a P/E ratio of 12.51x, ARCHITORG is currently trading below its industry average P/E of 20.98x. The company has a Return on Equity (ROE) of 7.62% and a debt-to-equity ratio of 0.39.
Archit Organosys Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Archit Organosys Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Archit Organosys Share Price: A ROCE-Focused Analysis
The commodity chemicals industry, often viewed as cyclical, presents hidden pockets of sustained value creation. These arise from efficient capital allocation and robust return on capital employed (ROCE). This analysis examines the current valuation of Archit Organosys share price, focusing on its ROCE efficiency. The current price is ₹41.029999, with a PE ratio of 12.51. A key metric in evaluating its financial health is its ROCE of 10.85%.
ROCE, measuring how effectively a company uses its capital to generate profits, is critical for long-term value creation. Archit Organosys Ltd's 10.85% ROCE suggests reasonable capital efficiency. A higher ROCE often indicates a stronger competitive moat. While not exceptionally high, a consistent ROCE above the cost of capital allows Archit Organosys to reinvest earnings strategically, potentially strengthening its market position and creating a self-reinforcing cycle of growth. However, maintaining this ROCE in the face of commodity price fluctuations and input cost pressures will be a key determinant of future performance.
Comparing Archit Organosys to its peers provides valuable context. Examining companies such as
AG Ventures can reveal relative strengths and weaknesses. For example, while AG Ventures' financials might appear superficially similar, a deeper dive into their management quality, capital allocation decisions, and operational efficiency could highlight significant differences in their ability to sustain high ROCE over the long term. Consistent high ROCE is often a reflection of strong management stewardship and efficient operational processes.Ultimately, the sustainability of Archit Organosys's competitive advantage hinges on its ability to maintain and improve its ROCE. Continued monitoring of its capital allocation decisions, operational efficiency, and response to market dynamics is crucial for assessing its long-term investment potential. This analysis forms part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, designed to provide a holistic view of Archit Organosys Ltd's financial standing. This analysis is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Archit Organosys Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ARCHITORG across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Attractive Valuation (P/E: 12.51 vs Industry: 20.98)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (50.98%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (44.16% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (50.70% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (5.07x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹50.23 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (65.39%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Below-Average Return on Equity (7.62%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Archit Organosys Ltd Financial Statements
Comprehensive financial data for Archit Organosys Ltd including income statement, balance sheet and cash flow
About ARCHITORG (Archit Organosys Ltd)
Archit Organosys Ltd is a dynamic entity deeply embedded in the global commodity chemical landscape. It specializes in the creation and distribution of a diverse portfolio of chemi...cal solutions that serve as the foundational building blocks for numerous industries. ARCHITORG's operations are centered around the meticulous crafting of essential chemical compounds, supplying the raw materials that fuel advancements across sectors ranging from agriculture to personal care. The company meticulously oversees every stage of its supply chain, ensuring the consistent delivery of high-quality products that meet stringent international standards. Through a combination of cutting-edge manufacturing techniques and a commitment to sustainable practices, ARCHITORG strives to be a reliable and responsible partner for its customers worldwide. At the heart of ARCHITORG's product offerings are vital chemical intermediates and specialty chemicals tailored for specific applications. Key products include monochloroacetic acid (MCA) and its derivative, sodium monochloroacetate (SMCA), critical ingredients in the synthesis of agrochemicals, cosmetic surfactants, oil drilling fluids, and plastic additives. Beyond these core products, ARCHITORG also offers a range of carefully formulated organic chemicals, high-performance pigments, and specialty derivatives, providing a spectrum of solutions for diverse industrial needs. The company further strengthens its market position through the production of adhesives and sealants under its proprietary AOL brand, offering reliable bonding and sealing solutions across construction and manufacturing sectors. ARCHITORG's global presence extends its reach beyond national boundaries, catering to a broad spectrum of clients across international markets. With a strong focus on customer satisfaction and a commitment to building long-term partnerships, the company strives to provide tailored solutions and exceptional service to its diverse clientele. Formerly known as Shri Chlochem Limited, ARCHITORG has undergone a transformative evolution, building upon its legacy of chemical expertise to become a leading player in the commodity chemical industry. The company continues to invest in research and development, exploring innovative solutions and expanding its product portfolio to meet the ever-evolving needs of its global customers.
Company Details
Key Leadership
Corporate Events
ARCHITORG Share Price: Frequently Asked Questions
What is the current share price of Archit Organosys Ltd (ARCHITORG)?
As of 30 Mar 2026, 12:01 pm IST, Archit Organosys Ltd share price is ₹36.16. The ARCHITORG stock has a market capitalisation of ₹82.68 (Cr) on NSE/BSE.
Is ARCHITORG share price Overvalued or Undervalued?
ARCHITORG share price is currently trading at a P/E ratio of 12.51x, compared to the industry average of 20.98x. Based on this relative valuation, the Archit Organosys Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of ARCHITORG share price?
The 52-week high of ARCHITORG share price is ₹51.45 and the 52-week low is ₹34.00. These values are updated daily from NSE/BSE price data.
What factors affect the Archit Organosys Ltd share price?
Key factors influencing ARCHITORG share price include quarterly earnings growth (Sales Growth: 11.24%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Archit Organosys Ltd a good stock for long-term investment?
Archit Organosys Ltd shows a 5-year Profit Growth of 50.70% and an ROE of 7.62%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.39 before investing in ARCHITORG shares.
How does Archit Organosys Ltd compare with its industry peers?
Archit Organosys Ltd competes with major peers in the Commodity Chemicals. Investors should compare ARCHITORG share price P/E of 12.51x and ROE of 7.62% against the industry averages to determine competitive standing.
What is the P/E ratio of ARCHITORG and what does it mean?
ARCHITORG share price has a P/E ratio of 12.51x compared to the industry average of 20.98x. Investors pay ₹13 for every ₹1 of annual earnings.
How is ARCHITORG performing according to Bull Run's analysis?
ARCHITORG has a Bull Run fundamental score of 63.1/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ARCHITORG belong to?
ARCHITORG operates in the Commodity Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Archit Organosys Ltd share price.
What is Return on Equity (ROE) and why is it important for ARCHITORG?
ARCHITORG has an ROE of 7.62%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Archit Organosys Ltd generates profits from shareholders capital.
How is ARCHITORG debt-to-equity ratio and what does it indicate?
ARCHITORG has a debt-to-equity ratio of 0.39, which indicates moderate leverage that should be monitored.
What is ARCHITORG dividend yield and is it a good dividend stock?
ARCHITORG offers a dividend yield of 1.24%, meaning you receive ₹1.24 annual dividend for every ₹100 invested in Archit Organosys Ltd shares.
How has ARCHITORG share price grown over the past 5 years?
ARCHITORG has achieved 5-year growth rates of: Sales Growth 10.37%, Profit Growth 50.70%, and EPS Growth 44.16%.
What is the promoter holding in ARCHITORG and why does it matter?
Promoters hold 65.39% of ARCHITORG shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Archit Organosys Ltd.
What is ARCHITORG market capitalisation category?
ARCHITORG has a market capitalisation of ₹83 crores, placing it in the Small-cap category.
How volatile is ARCHITORG stock?
ARCHITORG has a beta of N/A. A beta > 1 suggests the Archit Organosys Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ARCHITORG operating profit margin trend?
ARCHITORG has a 5-year average Operating Profit Margin (OPM) of 11.31%, indicating the company's operational efficiency.
How is ARCHITORG quarterly performance?
Recent quarterly performance shows Archit Organosys Ltd YoY Sales Growth of 11.24% and YoY Profit Growth of 50.98%.
What is the institutional holding pattern in ARCHITORG?
ARCHITORG has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Archit Organosys Ltd stock.